ANTIGENIC VARIATION IN GP120S FROM MOLECULAR CLONES OF HIV-1 LAI

被引:25
作者
MOORE, JP
YOSHIYAMA, H
HO, DD
ROBINSON, JE
SODROSKI, J
机构
[1] NYU,SCH MED,AARON DIAMOND AIDS RES CTR,NEW YORK,NY 10018
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115
关键词
D O I
10.1089/aid.1993.9.1185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To address the relationship between primary sequence variation in HIV-1 gp120 and its antigenic structure in a simple system, we have measured the binding of human and murine monoclonal antibodies (MAbs) to gp120 from four molecular clones of HIV-1 LAI: HxB2, HxB3, Hx10, and NL4-3. Despite the close relationship between these clones, and their relatively conserved gp120 sequences, there is considerable variation in their antigenic structure, judged by MAb reactivities to the V2, V3, and C4 domains and to discontinuous epitopes. Because of our prior studies of the determinants of MAb binding to HxB2 gp120, we can make reasonable estimates of how sequence variation among the LAI clone gp120s affects their binding of some MAbs; for other MAbs our current knowledge of gp120 structure is too limited to allow such estimates. These results indicate that small variations in primary gp120 amino acid sequence can profoundly affect recognition of this glycoprotein by all five groups of defined anti-gp120 neutralizing antibodies.
引用
收藏
页码:1185 / 1193
页数:9
相关论文
共 67 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[3]   MAJOR GLYCOPROTEIN ANTIGENS THAT INDUCE ANTIBODIES IN AIDS PATIENTS ARE ENCODED BY HTLV-III [J].
ALLAN, JS ;
COLIGAN, JE ;
BARIN, F ;
MCLANE, MF ;
SODROSKI, JG ;
ROSEN, CA ;
HASELTINE, WA ;
LEE, TH ;
ESSEX, M .
SCIENCE, 1985, 228 (4703) :1091-1094
[4]   NEUTRALIZING ANTIBODY-RESPONSE DURING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - TYPE AND GROUP SPECIFICITY AND VIRAL ESCAPE [J].
ARENDRUP, M ;
SONNERBORG, A ;
SVENNERHOLM, B ;
AKERBLOM, L ;
NIELSEN, C ;
CLAUSEN, H ;
OLOFSSON, S ;
NIELSEN, JO ;
HANSEN, JES .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :855-863
[5]   PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].
BERMAN, PW ;
GREGORY, TJ ;
RIDDLE, L ;
NAKAMURA, GR ;
CHAMPE, MA ;
PORTER, JP ;
WURM, FM ;
HERSHBERG, RD ;
COBB, EK ;
EICHBERG, JW .
NATURE, 1990, 345 (6276) :622-625
[6]   PROSPECTS FOR PREVENTION OF AND EARLY INTERVENTION AGAINST HIV [J].
BOLOGNESI, DP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (20) :3007-3013
[7]  
CHAMAT S, 1992, J IMMUNOL, V149, P649
[8]   HTLV-III ENV GENE-PRODUCTS SYNTHESIZED IN ESCHERICHIA-COLI ARE RECOGNIZED BY ANTIBODIES PRESENT IN THE SERA OF AIDS PATIENTS [J].
CROWL, R ;
GANGULY, K ;
GORDON, M ;
CONROY, R ;
SCHABER, M ;
KRAMER, R ;
SHAW, G ;
WONGSTAAL, F ;
REDDY, EP .
CELL, 1985, 41 (03) :979-986
[9]  
DURDA PJ, AIDS RES HUM RETROV, V4, P331
[10]   STRUCTURE-FUNCTION-RELATIONSHIPS OF THE HIV-1 ENVELOPE V3 LOOP TROPISM DETERMINANT - EVIDENCE FOR 2 DISTINCT CONFORMATIONS [J].
EBENBICHLER, C ;
WESTERVELT, P ;
CARRILLO, A ;
HENKEL, T ;
JOHNSON, D ;
RATNER, L .
AIDS, 1993, 7 (05) :639-646